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706Objective: Despite increasing use of bilateral branch pulmonary artery banding (bPAB), both as a temporary
stabilizing treatment and as part of comprehensive hybrid management of hypoplastic left heart syndrome, little
is known about the long-term outcomes of the pulmonary arteries (PAs) in banded patients.
Patients andMethods:We conducted a retrospective review of all patients with ductal-dependent systemic cir-
culation (2001-2013) undergoing bPAB placement at a single institution (bPAB, n ¼ 50); patients who under-
went a stage I Norwood procedure (Norwood, n¼ 53) were used for comparison. The need for PA interventions
(surgical arterioplasty, balloon angioplasty, and stent implantation) and PA growth were assessed.
Results: Bands were in place for a median of 76 days. PA growth and size were similar between groups, but
bPAB patients required more interventions (1.4  2.9 vs 0.5  1.2, P ¼ .01). In competing risks analysis,
only 20% of bPAB patients were alive and free from intervention at 5 years after bPAB removal. Multivariable
Cox proportional hazards regression of operative interventions within the bPAB group demonstrated the
following risk factors: subsequent 2-ventricle repairs (hazard ratio [HR], 2.2; 95% confidence interval [CI],
0.7-6.7), smallest band diameter (HR per additional millimeter, 0.059; 95% CI, 0.004-0.849), and duration
of band placement more than 90 days (HR, 3.5; 95% CI, 1.0-12.6). Hemodynamics and Fontan candidacy
did not differ between groups.
Conclusions: Patients with bPAB require additional interventions at earlier time points than Norwood patients.
Patients with smaller bands and longer duration of banding are at high risk. Despite stenoses requiring additional
interventions, Fontan candidacy is maintained. (J Thorac Cardiovasc Surg 2014;147:706-12)Bilateral branch pulmonary arterial banding (bPAB) is an
attractive method for control of pulmonary blood flow in
ductal-dependent lesions. It is performed both as part of a
comprehensive strategy for hybrid palliation and to stabilize
patients in the immediate postnatal period with pulmonary
overcirculation and ductal-dependent blood flow.1-4
Pulmonary arterial banding has important consequences
on the vascular wall that may result in important long-
term consequences to pulmonary arterial growth poten-
tial.1-6 Patients with hypoplastic left heart syndrome
undergoing a comprehensive stage 2 procedure have an
increased need for pulmonary artery interventions.3,6
Whether this is a consequence of the stage 2 operation or
attributable to the bPABs and whether particular patients
might be at high risk for pulmonary arterial stenosis and
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The Journal of Thoracic and Cardiovascular SurgAt our institution, bPAB has been used both as part of a
comprehensive hybrid management strategy and for imme-
diate stabilization in both single-ventricle and 2-ventricle
patients with ductal-dependent lesions. We undertook a re-
view of all patients undergoing bPAB placement to evaluate
the impact of bPAB on the long-term outcomes of the pul-
monary artery (PA), identify risk factors for poor outcomes,
and suggest strategies to mitigate the negative impact of
bPABs.METHODS
Patient Population
We performed a retrospective review of all patients undergoing
bPAB at a single institution (bPAB, n ¼ 50). These patients were
compared with a contemporaneous group of patients undergoing stage
1 Norwood palliation (Norwood, n ¼ 54). Diagnoses and birth history
are shown in Table 1. Overall median follow-up was 32.9 months (intra-
quartile range [IQR], 4.3-69.6). The Nemours Institutional Review
Board approved the study.
Surgical and Interventional Procedure Performed
During this time period, patients underwent either bPAB or standard
surgical palliation based on preoperative condition and physician prefer-
ence. Technical details of patients undergoing bPAB have been reported
previously.7 In summary, bPABs of polytetrafluoroethylene were placed
without cardiopulmonary bypass and typically over a 2.5-mm probe.
Band tightness was adjusted to maintain systemic oxygen saturation in
the 80% to 85% range. In selected patients, bPABs were placed before
either ductal stenting, stage 1 Norwood palliation, or definitive 2-
ventricle repair to stabilize patients with excessive pulmonary artery bloodery c February 2014
Abbreviations and Acronyms
BDG ¼ bidirectional Glenn
bPAB ¼ branch pulmonary arterial banding
CI ¼ confidence interval
HR ¼ hazard ratio
IQR ¼ intraquartile range
OR ¼ odds ratio
PA ¼ pulmonary artery
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Dflow and/or maldistribution of cardiac output. Modified stage 1 Norwood
palliation was performed using deep hypothermic circulatory arrest; pul-
monary blood flow was provided by either a right ventricle (RV)-pulmo-
nary artery (PA) conduit or a modified Blalock-Taussig shunt.
Superior cavopulmonary connections were usually performed using
a hemi-Fontan connection constructed of pulmonary homograft. Bidi-
rectional Glenn (BDG) anastomoses were used at the surgeon’s
discretion.
Hemodynamics and Measurements of Pulmonary
Arterial Size and Growth
Diagnostic catheterizations for all patients were reviewed. Branch PA
size was reported as the smallest diameter within that branch before hilar
branching. Sizes are reported both as raw data and indexed to patient
body surface area. Growth was measured as the difference between the first
and last measured size among patients with size measurements at least
6 months apart divided by the elapsed time. When calculating growth rates,
interval interventions were ignored. Hemodynamic measurements were
obtained from catheterization reports. Mean PA pressures are reported
and are the lowest reported pressures within the main and branch PAs prox-
imal to any significant stenoses with the branch PAs. Prestage 2 and pre-
Fontan data were defined as the last catheterization containing the relevant
measurement before performance of the respective surgery.
Operative and Catheter-Based Interventions
Operative interventions were defined as any surgical procedure
involving an attempt to address branch PA stenosis: patch arterioplasty,
excision and reconstruction of a pulmonary artery segment, rigid or balloon
dilation, or placement of a stent via an open surgical procedure. Because
the hemi-Fontan was performed routinely, this was not included as an oper-
ative intervention on the PAs (nor was placement of a BDG anastomosis).
Catheter-based interventions were limited to either balloon angioplasty or
stent placement in the PA. Interventions directed at other lesions (eg, re-
coarctation) were not included. Patients requiring more than 1 intervention
on separate dates were considered to have undergone multiple
interventions.
Statistical Analysis
Statistical analysis was conducted using SAS 9.2 for AIX (SAS Institute
Inc, Cary, NC). Statistical tests used to identify predictors of outcomes
included the c2-test and the paired t test. Duration of bPAB placement
was analyzed both as a continuous variable and stratified into 3 groups:
14 or less days, 14 to 90 days, and more than 90 days. Time-to-event out-
comes were assessed with Kaplan-Meier survival estimates (log-rank rest
for difference between strata, P<.05). Multivariate regression of binary
outcomes was performed using logistic regression (backward selection,
P<.2 to remain). Cox proportional hazards regression was used to identify
risk-adjustedmodels for time-to-event analyses (backward selection, P<.2
to remain). Competing risks analysis was performed using the cmprisk
package of R for Windows.The Journal of Thoracic and CaRESULTS
Baseline demographics, birth history, and preoperative
clinical condition for Norwood and bPAB patients are
shown in Table 1. Median follow-up was longer among
theNorwood patients (51.3months [IQR, 16.2-82.5months]
vs bPAB:10.9 months [3.3-46.7 months], P ¼ .01).
Median bPAB diameter was 2.5 mm for both right and
left PA (range, 2.0-3.5 mm). Ductal stenting was performed
during the same procedure as bPAB in 14 patients (28.0%),
and an additional 17 patients (62.0%) had insertion of a
ductal stent as a separate procedure. When performed as a
separate procedure, the ductal stent was placed a median
of 6.5 days (IQR, 4-11) after bPAB.
Adjustment of band diameter was necessary in 8 patients
(16.0%) at a median of 6.5 days (IQR, 0-24 days) after band
placement. Bands were in place for a median of 76 days
(IQR, 18-103 days) before either removal or patient death.
There was a trend toward higher in-hospital mortality
among the bPAB patients (Norwood, 13.0%; bPAB,
26.0%; P ¼ .09).
Superior cavopulmonary connections were created in 56
patients at a median of 5.4 months of age (IQR,
4.4-6.7 months). The Fontan procedure was performed in
34 patients at a median of 18.3 months (IQR, 14.7-
23.5 months). Creation of a superior cavopulmonary anas-
tomosis was more common among the Norwood patients
(64.9% vs 42.0%; P ¼ .02), and there was a trend toward
a higher incidence of eventual Fontan palliation among
Norwood patients (38.9% vs 26.0%; P ¼ not significant
[NS]). Two-ventricle repairs were performed in 17 patients
at a median of 3.8 months of age (IQR, 2.1-5.8 months). A
higher proportion of bPAB patients ultimately underwent a
2-ventricle repair (26.0% vs 7.4%; P ¼ .01). Heart trans-
plant was performed in 1 patient after a Norwood procedure
and in 2 patients after bPAB.
Pulmonary Arterial Growth and Size
Right and left pulmonary arterial size (both raw and
indexed to body surface area) did not differ significantly
between groups at any defined time during follow-up
(Table 2). Left pulmonary arterial growth was
1.3  1.5 mm/y in Norwood patients and 0.6  1.5 mm/y
(P ¼ .15). Indexed growth measurements in the left PA
were 4.7  4.3 mm/y/m2 in the Norwood patients and
1.7  10.9 mm/y/m2 in the bPAB patients (P ¼ .3). Right
PA growth was also not different between groups, either
nonindexed (Norwood: 1.7  4.7 mm/y vs bPAB
3.7  5.2 mm/y; P ¼ .2) or indexed (Norwood
2.5  1.5 mm/y/m2 vs bPAB 3.3  1.9 mm/y/m2;
P ¼ .3). Left and right PA size and band removal and sub-
sequent PA growth did not differ between patients undergo-
ing single- versus 2-ventricle repairs.
Obliteration of a branch PA occurred in 2 Norwood
patients and 1 bPAB patient (P ¼ NS). Obliteration of ardiovascular Surgery c Volume 147, Number 2 707
TABLE 1. Baseline demographics and clinical variables among
patients undergoing bilateral pulmonary arterial banding (bPAB) or
stage 1 Norwood palliation
Norwood
(n ¼ 54)
bPAB
(n ¼ 50)
P
value
Age (d, mean  SD) 13.8  27.9 8.6  10.1 NS
Weight (kg, mean  SD) 3.3  0.6 2.6  0.7 <.0001
Gestational age (wk, mean  SD) 38.4  1.6 36.5  2.9 .0004
Birth weight (kg, mean  SD) 3.2  0.6 2.5  0.7 <.0001
Gender (male), n (%) 29 (53.7) 33 (66.0) NS
Genetic syndrome, n (%) 4 (8.3) 9 (20.0) .1
Noncardiac congenital abnormality,
n (%)
5 (13.5) 7 (26.9) NS
Premature, n (%) 5 (10.4) 14 (30.4) .016
Diagnosis, n (%)
Hypoplastic left heart syndrome 32 (59.3) 25 (50.0) NS
Atrioventricular septal defect 5 (9.3) 5 (10.0) NS
Interrupted aortic arch 4 (7.4) 3 (6.0) NS
Transposition of the great arteries 2 (3.7) 2 (4.0) NS
Double-outlet right ventricle 4 (7.4) 3 (6.0) NS
Truncus arteriosus 0 (0.0) 3 (6.0) .06
Ebstein anomaly 0 (0.0) 1 (2.0) NS
Mitral atresia 15 (27.8) 14 (28.0) NS
Aortic atresia 22 (40.7) 18 (36.0) NS
Preoperative variables, n (%)
Mechanical ventilation 3 (5.9) 28 (56.0) <.0001
Extracorporeal membrane
oxygenation
1 (2.0) 2 (4.0) NS
Ventricular dysfunction 2 (4.7) 14 (29.2) .002
Atrioventricular valve regurgitation
moderate or higher
4 (9.8) 7 (14.3) NS
Preoperative shock 3 (6.1) 12 (26.1) .008
Operative variables
Cardiopulmonary bypass time
(min, mean  SD)
143  56 N/A
DHCA time (min, mean  SD) 57  21.4 N/A
SD, Standard deviation; N/A, not available.
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Dlobar branch occurred in 4 Norwood patients (7.4%) and 6
bPAB patients (12.0%; P ¼ NS).
Pulmonary Arterial Interventions
A total of 335 catheterizations were performed. Balloon
angioplasty of the left PAwas performed in 26 catheteriza-
tions (Norwood, 2; bPAB, 24) and of the right PA in 17 cath-
eterizations (Norwood, 4; bPAB, 13). Stent implantation
occurred in the left PA in 14 catheterizations (Norwood,
3; bPAB, 11) and in the right PA in 3 catheterizations
(bPAB, 3).
The percentage of patients requiring any catheter-based
intervention was similar between the groups (Norwood, 8
[14.8%]; bPAB, 12 [24.0%]; P ¼ .2), but patients in the
bPAB group required a greater number of diagnostic and in-
terventional catheterizations during follow-up (Figure 1).
The need for multiple pulmonary arterial interventions
was higher among the bPAB group (11 of 50, 22.0% vs 4708 The Journal of Thoracic and Cardiovascular Surgof 54, 7.4%, P¼ .03). Intervention-free survival was worse
among the pPAB group (Figure 2). Competing risks anal-
ysis demonstrates that at 5 years only 20% of bPAB patients
remain alive and free from intervention, compared with
51% of Norwood patients (Figure 3; P ¼ .057).
Among all patients, those ultimately undergoing
2-ventricle repairs had a higher incidence of requiring inter-
ventional catheterizations (47.1% vs 13.8%; P ¼ .0015).
The timing of interventions was evenly distributed between
before, concurrent with, and after the 2-ventricle repair. The
need for PA interventions was more common on both the
right PA (2-ventricle, 6 of 17 [35.3%] vs 1-ventricle, 6 of
87 [6.9%]; P ¼ .0008) and the left PA (2-ventricle, 6 of
17 [35.3%] vs 1-ventricle 8 of 87 [9.2%]; P ¼ .004). The
risk of multiple interventions was higher in the 2-ventricle
patients in both the right PA (11.8% vs 1.2%; P ¼ .01)
and left PA (29.4% vs 3.5%, P ¼ .0002).
Risk of Multiple Pulmonary Arterial Interventions
Among bPAB Patients
Preoperative factors (including patient age at bPAB
placement, gestational age, and birthweight) did not predict
the need for multiple PA interventions. Patients requiring
subsequent adjustment of bPAB diameter or position did
not have a significantly higher risk of multiple reinterven-
tions (no adjustment, 12.5% vs adjusted, 23.8%;
P ¼ NS). The tightening of left and right bands to different
diameters also did not result in a significant increase in the
incidence of multiple reinterventions (identical diameter,
16.7% vs nonidentical diameter, 23.7%; P ¼ NS). There
was a trend toward longer duration of band placement in pa-
tients requiring multiple PA interventions (103 65 days vs
65  53 days; P ¼ .06), and patients banded for more than
90 days had a higher incidence of multiple PA interventions
(36.8% vs 12.9%; P ¼ .047). Patients who subsequently
underwent a 2-ventricle repair after bPAB had a higher inci-
dence of requiring multiple PA interventions (46.2% vs
13.5%; P ¼ .01). Multiple interventions on the left PA
were particularly common in the 2-ventricle patients
(38.5% vs 8.1%; P ¼ .01); although multiple interventions
on the right PA were similar regardless of the number of
ventricles (2 ventricles, 7.7%; 1 ventricle, 2.7%;
P ¼ NS). Use of comprehensive stage1/stage2 versus sepa-
rate stage 1 and stage 2 procedures among the single-
ventricle bPAB patients was not associated with an
increased need for multiple PA interventions (20.0%
comprehensive vs 11.1%; P ¼ NS).
Freedom From Intervention
In univariate analysis, none of the preoperative or intrao-
perative risk factors were significant predictors of freedom
from catheter or operative interventions. Multivariable Cox
proportional hazards regression of operative interventions
within the bPAB group demonstrated the following riskery c February 2014
TABLE 2. Left and right mean pulmonary artery size measurements
Norwood bPAB P value
After bPAB removal or Norwood* (n ¼ 60)
Left PA (mm)/left PA index (mm/m2) 3.8  1.9/11.6  5.1 4.2  3.3/12.4  7.6 NS/NS
Right PA (mm)/right PA index (mm/m2) 4.7  3.9/14.8  5.5 5.6  3.8/14.5  6.3 NS/NS
Prestage 2 (n ¼ 29)
Left PA (mm)/left PA index (mm/m2) 3.9  3.2/11.5  3.9 3.5  2.4/14.0  5.2 NS/.06
Right PA (mm)/right PA index (mm/m2) 5.0  1.7/15.6  5.0 3.9  0.6/15.1  5.6 .04/NS
Pre-Fontan (n ¼ 22)
Left PA (mm)/left PA index (mm/m2) 4.2  3.3/8.7  2.9 4.3  3.0/12.1  5.1 NS/.07
Right PA (mm)/right PA index (mm/m2) 8.0  1.8/16.8  3.3 6.9  1.5/16.1  1.8 .14/NS
Pre2-ventricle repair (n ¼ 5)
Left PA (mm)/left PA index (mm/m2) 4.2  2.3/13.7  8.0 3.6  2.5/10.8  9.6 NS/NS
Right PA (mm)/right PA index (mm/m2) 2.5  2.1/8.1  6.8 4.0  1.7/10.9  2.7 NS/NS
Final measurement
Left PA (mm)/left PA index (mm/m2) 5.3  4.9/15.7  5.1 4.9  1.7/16.8  5.7 NS/NS
Right PA (mm)/right PA index (mm/m2) 7.7  3.3/15.7  5.1 8.2  4.5/16.7  6.0 NS/NS
bPAB, Bilateral pulmonary arterial banding; PA, pulmonary artery; NS, not significant. *For bPAB patients, the first size measurement is after bPAB removal; for Norwood
patients, it is after the Norwood procedure.
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Norwood bPAB
Catheter Based Operative Total
Catheter-based and Operative Interventions
p = 0.01
p = 0.03
p = 0.03
p = NS
p = 0.06
FIGURE 1. The mean number of catheterizations and operative interven-
tions on the pulmonary arteries performed in the Norwood group (white
columns) and the bilateral pulmonary arterial banding (bPAB) group (black
columns). 95% confidence intervals of the means are illustrated by error
bars. PA, Pulmonary artery.
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Dfactors: subsequent 2-ventricle repairs (hazard ratio [HR],
2.2; 95% confidence interval [CI], 0.7-6.7), smallest band
diameter (HR per additional millimeter, 0.059; 95% CI,
0.004-0.849), and duration of band placement for more
than 90 days (HR, 3.5; 95% CI, 1.0-12.6). Risk factors
were the same for both catheter-based interventions and
any intervention. Gestational age and birthweight did not
predict freedom from interventions in multivariable
analysis.
Multivariable analysis of all patients identified the use of
bPABs (HR, 3.8; 95% CI, 1.5-9.6) and a diagnosis of inter-
rupted aortic arch (HR, 3.8; 95% CI, 1.3-11.5) as predictive
of earlier risk of operative intervention. Gestational age,
birthweight, genetic syndromes, and other diagnoses were
not predictive of operative interventions.
Hemodynamics
The ratio of pulmonary vascular resistance to systemic
resistance was not different between PA band and non-PA
band patients at the prestage 2 catheterization (Norwood,
0.13  0.11; bPAB, 0.13  0.12; P ¼ NS) or at the pre-
Fontan catheterization (Norwood, 0.13  0.03; bPAB,
0.15  0.03; P ¼ NS). PA pressures were also similar at
both prestage 2 (Norwood, 12.9  2.2; bPAB, 12.6  3.2;
P ¼ NS) and pre-Fontan (Norwood, 10.4  1.5; bPAB,
10.5  2.1; P ¼ NS) catheterizations. Mean pressure in
the superior cavopulmonary connection before Fontan was
similar as well (Norwood, 12.0  2.1; bPAB, 12.1  2.2;
P ¼ NS). No patients in either group were excluded from
candidacy for Fontan based on hemodynamic assessments
of the PAs at the pre-Fontan catheterization.
DISCUSSION
This study evaluates the impact of bPAB placement on
subsequent pulmonary arterial growth and the need forThe Journal of Thoracic and Cainterventions. We have shown that patients undergoing
bPAB placement require early and repeated operative and
catheter-based interventions after bPAB removal. This
finding is consistent with the limited data currently
available.3,6
Pulmonary arterial banding induces regional inflamma-
tion within the vascular wall and ischemic injury resulting
in the loss of cells in the media.2,4,8 Changes in
pulmonary vascular wall morphology are present within
2 weeks, but fibrosis occurs later.4 Although the traditional
use of the PA band on the pulmonary trunk is associated
with the need for pulmonary arterioplasty at the time of de-
banding, repair of the pulmonary trunk has better outcomesrdiovascular Surgery c Volume 147, Number 2 709
FIGURE 2. Five-year Kaplan-Meier survival estimates of freedom from
operative intervention (A) and catheter-based interventions (B) on the pul-
monary arteries.
FIGURE 3. Competing risks analysis of patients after: A, Norwood oper-
ation; B, removal of bilateral pulmonary arterial banding (bPAB). Cumula-
tive incidence of 3 competing outcomes is shown: death (solid black line),
intervention (dashed black line), and alive without intervention (dotted
black line). Comparison of cumulative incidence between groups: death
(P ¼ .057), intervention (P ¼ .15).
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Dthan repairs of similar lesions on the more distal branch
PAs.9 Whether the vascular damage inherent to pulmonary
arterial banding has long-term negative effects on branch
PAs has been only minimally investigated.3,10
In a study of patients undergoing hybrid stage 1 proce-
dures, Baba and colleagues3 have shown that patients un-
dergoing hybrid palliation have an increased need for
reintervention and a lower Nakata index. Whether this is
primarily related to the bPAB or to technical issues at the
comprehensive stage 2 procedure as the authors postulate
is not clear. Our data confirm the increased need for pulmo-
nary interventions after bPAB.
We did not find that the use of a comprehensive stage 2
palliation was associated with subsequent pulmonary artery
interventions; this suggests that the long-term need for710 The Journal of Thoracic and Cardiovascular Surgreintervention is primarily related to the bPABs rather
than the effects of the comprehensive stage 2 procedure.
In addition, we found that smaller PA band diameter was
associated with need for reintervention, and that PA band
duration longer than 90 days was particularly detrimental
to the branch PAs. Both these findings provide further evi-
dence for the idea that it is the bPAB procedure itself rather
than subsequent palliation that results in the high interven-
tion rate.
Although the use of larger diameter bPABs might be
reasonably expected to decrease the need for PA interven-
tion, the fundamental goal of band placement is control of
pulmonary blood flow. The margin of error for a band being
either too tight or too loose is small in neonatal patients
(particularly those with prematurity and low birth weight).ery c February 2014
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DComputer modeling suggests that banding to a 2-mm diam-
eter is advantageous for systemic and cerebral blood flow,11
but this may increase the risk of pulmonary vascular prob-
lems. Initial banding must be directed at providing adequate
systemic perfusion; however, it may be advantageous to err
on the side of a slightly larger band in the early period to
minimize the long-term risk to the PA.
Many of our patients have been managed with an initial
bPAB placement for hemodynamic stabilization in the im-
mediate postnatal period followed by a subsequent modified
stage 1 Norwood procedure. This approach has been
described by others.1 This limits the duration of bPAB
compared with the strategy of comprehensive stage 2.
Given the high risk of PA intervention associated with
longer duration of banding (especially >90 days), this
may provide advantages compared with the typical hybrid
path, particularly when the complicated nature of the
comprehensive stage 2 procedure is included.12
Although a bPAB duration of more than 90 days carried
the highest risk of reintervention, even patients with short
durations had an incidence of multiple PA interventions
exceeding 10%. This suggests that stenosis requiring inter-
vention may result from acute inflammation and surgical
dissection rather than longer-term alterations in pulmonary
arterial growth patterns.
We found that most preoperative factors were not signif-
icant predictors of the need for subsequent intervention.
However, there was clearly a higher risk for subsequent
PA interventions among patients who eventually underwent
2-ventricle repairs. One plausible explanation for this
finding is that most single-ventricle patients underwent a
hemi-Fontan procedure; this may have mitigated the risk
of subsequent pulmonary arterial interventions. However,
the hemi-Fontan primarily addresses right PA stenosis;
however, the risk of additional interventions in 2-ventricle
patients was particularly high in the left PA. This suggests
that additional factors may be at work. Patients with an in-
terrupted aortic arch were at particularly high risk; this may
be related to distortion of the retroaortic region during the
reconstructive surgery resulting in branch PA narrowing.
In addition, the site of the left PA band is at the same loca-
tion as the site found to be at risk of kinking in patients with
redundant main PAs after tetralogy of Fallot repair.13 In the
2-ventricle patients initially managed with bPABs, this site
may be vulnerable to small alterations in anatomy as would
be seen with insertion of a RV-PA conduit or procedures
directed at enlarging the pulmonary outflow. In contrast,
the superior cavopulmonary connection used in the
single-ventricle patients may address the right PA band
site without altering the anatomy of the left PA site. These
findings suggest the critical importance of preserving the
normal course of the left PA in 2-ventricle repairs and per-
forming concurrent left PA reconstruction where indicated.
As additional patients undergo bPAB, further investigationThe Journal of Thoracic and Cainto the outcomes among 2-ventricle patients may elucidate
the mechanisms underlying the need for additional
interventions.
It is reassuring that among all patients, pulmonary arterial
size and growth rates were not lower among patients with
bPAB placement. This suggests that the interventions are
having the appropriate effect, at least in the midterm. He-
modynamics were also not affected significantly, and pul-
monary arterial problems did not result in loss of Fontan
candidacy.
Long-term successful Fontan palliation is dependent on a
low pulmonary vascular resistance. Follow-up in this study
is limited because of the recent increase in the use of bPAB.
The long-term impact of multiple reinterventions on pulmo-
nary arterial growth (both central and peripheral) is not
clear. It remains to be seen whether long-term Fontan circuit
pressures and ultimately clinical failure rates will be
affected by the multiple pulmonary arterial interventions
required to bring them to Fontan. Few data exist on the
long-term effects on distal pulmonary architecture and
this merits further follow-up.
Limitations
This was a retrospective review and the 2 cohorts differed
in terms of preoperative risk factors. Althoughmost of these
risk factors would be expected to primarily affect mortality
rather than the need for pulmonary arterial interventions, we
cannot exclude the possibility that factors such as prematu-
rity and low birth weight have long-term consequences for
pulmonary arterial growth. However, in multivariable anal-
ysis, management strategy seemed to be the most important
predictor of the need for PA interventions. Furthermore,
analysis of risk factors within the bPAB group was unaf-
fected by the lack of randomization. The more limited
follow-up (with higher early mortality) among patients
with bPAB may have reduced the negative impact of
bPAB or obscured a difference in growth that would be
apparent with longer follow-up in more patients.
CONCLUSIONS
The use of bPABs results in a significant increase in pul-
monary arterial interventions. Patients with bPABs, espe-
cially those with smaller diameter bands and longer band
placement, require a significant number of pulmonary arte-
rial interventions. The use of bPAB in 2-ventricle patients
may be particularly problematic. Despite these challenges,
midterm PA size, hemodynamics, pulmonary vascular resis-
tance, and Fontan candidacy seem to be maintained through
multiple interventions. Long-term outcomes remain
unclear.
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